-
Radius Health (RDUS) PT Lowered to $39 at Citi
-
Radius Health Announces Third Quarter 2019 Results and Corporate Update
-
Radius Health Announces Third Quarter 2019 Results and Corporate Update
-
Radius Health to Participate in the Citi 14th Annual Biotech Conference and Morgan Stanley 17th Annual Global Healthcare Conference in September
-
Radius Health to Participate in the Citi 14th Annual Biotech Conference and Morgan Stanley 17th Annual Global Healthcare Conference in September
-
Citi Upgrades Radius Health (RDUS) to Buy
-
Radius Health Announces Second Quarter 2019 Operating Results
-
Radius Health Announces Second Quarter 2019 Operating Results
-
Citi Assumes Radius Health (RDUS) at Neutral
-
Radius Health (RDUS) PT Lowered to $42 at Citi
-
Citi Starts Radius Health (RDUS) at Neutral
-
Radius Health Announces Pricing of $300 Million of 3.00% Convertible Senior Notes due 2024
-
Radius Health Reports Second Quarter 2017 Financial and Operating Results and Provides Business Update
-
Pre-Open Movers 05/22: (NUTR) (RDUS) (EYEG) Higher; (LJPC) (SNCR) (AMGN) Lower (more...)